Skip to main content
SpringerLink
Log in

Rotavirus Vaccines: A Review of the Work, Progress, and Contributions Made in Latin America

  • Chapter
  • First Online:
Human Virology in Latin America

Abstract

There are two licensed rotavirus (RV) vaccines worldwide, which have been safely used and efficacious in many countries, particularly in Latin American. Many of the clinical trials to evaluate the safety, efficacy and public health impact of these vaccines were conducted in Latin America. A summary of the part this region contributed to the development of these RV vaccines is described in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Angel J, Steele AD, Franco MA (2014) Correlates of protection for rotavirus vaccines: possible alternative trial endpoints, opportunities, and challenges. Hum Vaccin Immunother 10:3659–3671

    Article  PubMed  PubMed Central  Google Scholar 

  2. Armah GE, Kapikian AZ, Vesikari T et al (2013) Efficacy, immunogenicity, and safety of two doses of a tetravalent rotavirus vaccine RRV-TV in Ghana with the first dose administered during the neonatal period. J Infect Dis 208:423–431

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Armah GE, Sow SO, Breiman RF et al (2010) Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 376:606–614

    Article  CAS  PubMed  Google Scholar 

  4. Barnes GL, Lund JS, Mitchell SV et al (2002) Early phase II trial of human rotavirus vaccine candidate RV3. Vaccine 20:2950–2956

    Article  CAS  PubMed  Google Scholar 

  5. Bayard V, De Antonio R, Contreras R et al (2012) Impact of rotavirus vaccination on childhood gastroenteritis-related mortality and hospital discharges in Panama. Int J Infect Dis 16:e94–e98

    Article  PubMed  Google Scholar 

  6. Bernstein DI, Glass RI, Rodgers G et al (1995) Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. JAMA 273:1191–1196

    Article  CAS  PubMed  Google Scholar 

  7. Bernstein DI, Sack DA, Rothstein E et al (1999) Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial. Lancet 354:287–290

    Google Scholar 

  8. Bernstein DI, Smith VE, Sander DS et al (1990) Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis 162:1055–1062

    Article  CAS  PubMed  Google Scholar 

  9. Bernstein DI, Ward RL (2006) Rotarix: development of a live attenuated monovalent human rotavirus vaccine. Pediatr Ann 35:38–43

    Article  PubMed  Google Scholar 

  10. Bhan MK, Glass RI, Ella KM et al (2014) Team science and the creation of a novel rotavirus vaccine in India: a new framework for vaccine development. Lancet 383:2180–2183

    Article  PubMed  Google Scholar 

  11. Bhandari N, Rongsen-Chandola T, Bavdekar A et al (2014) Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet 383:2136–2143

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Bines JE, Danchin M, Jackson P et al (2015) Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 15:1389–1397

    Article  CAS  PubMed  Google Scholar 

  13. Bishop RF, Barnes GL, Cipriani E et al (1983) Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children. N Engl J Med 309:72–76

    Article  CAS  PubMed  Google Scholar 

  14. Borges AMT, Dias e Souza M, Fiaccadori FS et al (2011) Monitoring the circulation of rotavirus among children after the introduction of the Rotarix™ vaccine in Goiânia, Brazil. Mem Inst Oswaldo Cruz 106:499–501

    Article  PubMed  Google Scholar 

  15. Buttery JP, Standish J, Bines JE (2014) Intussusception and rotavirus vaccines: consensus on benefits outweighing recognized risk. Pediatr Infect Dis J 33:772–773

    Article  PubMed  Google Scholar 

  16. Carvalho-Costa FA, Volotão Ede M, de Assis RM et al (2011) Laboratory-based rotavirus surveillance during the introduction of a vaccination program, Brazil. Pediatr Infect Dis J 30:S35–S41

    Article  PubMed  Google Scholar 

  17. Clark HF, Bernstein DI, Dennehy PH et al (2004) Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants. J Pediatr 144:184–190

    Article  CAS  PubMed  Google Scholar 

  18. Clark HF, Borian FE, Bell LM et al (1988) Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J Infect Dis 158:570–587

    Article  CAS  PubMed  Google Scholar 

  19. Clark HF, Furukawa T, Bell LM et al (1986) Immune response of infants and children to low-passage bovine rotavirus (strain WC3). Am J Dis Child 140:350–356

    Article  CAS  PubMed  Google Scholar 

  20. Clark HF, Offit PA, Ellis RW et al (1996) The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants. J Infect Dis 174:S73–S80

    Article  PubMed  Google Scholar 

  21. Clark HF, Offit PA, Plotkin SA et al (2006) The new pentavalent rotavirus vaccine composed of bovine (strain WC3): human rotavirus reassortants. Pediatr Infect Dis J25:577–583

    Google Scholar 

  22. Clarke E, Desselberger U (2015) Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings. Mucosal Immunol 8:1–17

    Article  CAS  PubMed  Google Scholar 

  23. Correia JB, Patel MM, Nakagomi O et al (2010) Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. J Infect Dis 201:363–369

    Article  CAS  PubMed  Google Scholar 

  24. Costa I, Linhares AC, Cunha MH et al (2016) Sustained decrease in gastroenteritis-related death and hospitalizations in children aged <5 years after the introduction of rotavirus vaccination: a time trend analysis in Brazil (2001–2010). Pediatr Infect Dis J 35:e180–e190

    Article  PubMed  Google Scholar 

  25. Costes-Cantillo K, Paternima-Caicedo A, Coronell-Rodriguez W et al (2014) Effectiveness of the monovalent rotavirus vaccine in Colombia: a case-control study. Vaccine 32:3035–3040

    Article  CAS  Google Scholar 

  26. de Oliveira LH, Camacho LA, Coutinho ES et al (2015) Rotavirus vaccine effectiveness in Latin American and Caribbean countries: a systematic review and meta-analysis. Vaccine 33:A248–A254

    Article  PubMed  Google Scholar 

  27. de Oliveira LH, Giglio N, Ciapponi A et al (2013) Temporal trends in diarrhea-related hospitalizations and deaths in children under age 5 before and after the introduction of the rotavirus vaccine in four Latin American countries. Vaccine 31:C99–C108

    Article  PubMed  Google Scholar 

  28. de Palma O, Cruz L, Ramos H et al (2010) Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ 340:c2825

    Article  PubMed  PubMed Central  Google Scholar 

  29. De Vos B, Han HH, Bouckenooghe A et al (2009) Live attenuated human rotavirus vaccine, RIX4414, provides protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials. Pediatr Infect Dis 28:261–266

    Article  Google Scholar 

  30. De Vos B, Vesikari T, Linhares AC et al (2004) A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis. Pediatr Infect Dis J 23:S179–S182

    Article  PubMed  Google Scholar 

  31. Delem A, Lobmann M, Zygraich N (1984) A bovine rotavirus developed as a candidate vaccine for use in humans. J Biol Stand 12:443–445

    Article  CAS  PubMed  Google Scholar 

  32. Desai R, de Oliveira LH, Parashar UD et al (2011) Reduction in morbidity and mortality from childhood diarrhoeal disease after species A rotavirus vaccine introduction in Latin America: a review. Mem Inst Oswaldo Cruz 106:907–911

    Article  PubMed  Google Scholar 

  33. Desai R, Parashar UD, Lopman B et al (2012) Potential intussusception risk versus health benefitis from rotavirus vaccination in Latin America. Clin Infect Dis 54:1397–1405

    Article  PubMed  Google Scholar 

  34. do Carmo GM, Yen C, Siqueira AA et al (2011) Decline in diarrhea mortality and admissions after routine childhood immunization in Brazil: a time-series analysis. PLoS Med 8:e1001024

    Article  PubMed  PubMed Central  Google Scholar 

  35. Dulgheroff AC, Figueiredo EF, Moreira LP et al (2013) Distribution of rotavirus genotypes after vaccine introduction in Triângulo Mineiro region of Brazil: 4-year follow-up study. J Clin Virol 55:67–71

    Article  Google Scholar 

  36. Esteban LE, Rota LP, Gentsch JR et al (2010) Molecular epidemiology of group A rotavirus in Buenos Aires, Argentina 2004–2007: reemergence of G2P[4] and emergence of G9P[8] strains. J Med Virol 82:1083–1093

    Article  CAS  PubMed  Google Scholar 

  37. Flannery B, Samad S, de Moraes JC et al (2013) Uptake of oral rotavirus vaccine and timeliness of routine immunization in Brazil’s National Immunization Program. Vaccine 31:1523–1528

    Article  PubMed  PubMed Central  Google Scholar 

  38. Franco MA, Greenberg HB (2013) Rotavirus. Microbiol Spectr 1:1–10. doi:10.1128/microbiolspec. AID-001-2013

    Google Scholar 

  39. Gastañaduy PA, Sanchez-Uribe E, Esparza-Aguilar M et al (2013) Effect of rotavirus vaccine on diarrhea mortality in different socioeconomic regions of Mexico. Pediatrics 131:e1115–e1120

    Article  PubMed  Google Scholar 

  40. Gentsch JR, Laird AR, Bielfelt B et al (2005) Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis 192:S146–S159

    Article  PubMed  Google Scholar 

  41. Georges-Courbot MC, Monges J, Siopathis MR et al (1991) Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa. Res Virol 142:405–411

    Article  CAS  PubMed  Google Scholar 

  42. Glass RI, Bhan MK, Ray P et al (2005) Development of candidate rotavirus vaccines derived from neonatal strains in India. J Infect Dis 192:S30–S35

    Article  PubMed  Google Scholar 

  43. Glass RI, Parashar UD, Patel M (2014) Rotavirus vaccines: successes and challenges. J Infect 68:S9–S18

    Article  PubMed  Google Scholar 

  44. Guerra SFS, Linhares AC, Mascarenhas JDP et al (2015) Rotavirus strain surveillance for three years following the introduction of rotavirus vaccine into Belém, Brazil. J Med Virol 87:1303–1310

    Article  CAS  PubMed  Google Scholar 

  45. Gurgel RQ, Bohland AK, Vieira SC et al (2009) Incidence of rotavirus and all-cause diarrhea in northeast Brazil following the introduction of a national immunization program. Gastroenterology 137:1970–1975

    Google Scholar 

  46. Gurgel RQ, Alvarez Ade J, Rodrigues A et al (2014) Incidence of rotavirus and circulating genotypes in Northeast Brazil during 7 years of national rotavirus vaccination. PLoS One 9:e110217

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  47. Gurgel RQ, Correia JB, Cuevas LE (2008) Effect of rotavirus vaccination on circulating virus strains. Lancet 371:301–302

    Article  PubMed  Google Scholar 

  48. Gurgel RQ, Ilozue C, Correia JB et al (2011) Impact of rotavirus vaccination on diarrhoea mortality and hospital admissions in Brazil. Trop Med Int Health 16:1180–1184

    Article  PubMed  Google Scholar 

  49. Hanlon P, Hanlon L, Marsh V et al (1987) Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants. Lancet 1:1342–1345

    Article  CAS  PubMed  Google Scholar 

  50. Heaton PM, Ciarlet M (2007) Vaccines: the pentavalent rotavirus vaccine: discovery to licensure and beyond. Clin Infect Dis 45(12):1618–1624

    Article  PubMed  Google Scholar 

  51. Herrera D, Vásquez C, Corthésy B et al (2013) Rotavirus specific plasma secretory immunoglobulin in children with acute gastroenteritis and children vaccinated with an attenuated human rotavirus vaccine. Hum Vaccin Immunother 9:2409–2417

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Hoshino Y, Wagner M, Yan XY et al (2003) Horizontal transmission of rhesus monkey rotavirus-based quadrivalent vaccine during a phase 3 clinical trial in Caracas, Venezuela. J Infect Dis 187:791–800

    Article  PubMed  Google Scholar 

  53. Ichihara MYT, Rodrigues LC, Teles Santos CAS et al (2014) Effectiveness of rotavirus vaccine against hospitalized rotavirus diarrhea: a case-control study. Vaccine 32:2740–2747

    Article  CAS  PubMed  Google Scholar 

  54. Jiang B, Gentsch JR, Glass RI (2008) Inactivated rotavirus vaccines: a priority for accelerated vaccine development. Vaccine 26:6754–6758

    Article  CAS  PubMed  Google Scholar 

  55. Jiang J, Jiang B, Parashar U et al (2013) Childhood intussusception: a literature review. PLoS One 8:e68482

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Justino MC, Linhares AC, Lanzieri TM (2011) Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil. Pediatr Infect Dis J 30:396–401

    Article  PubMed  Google Scholar 

  57. Kapikian AZ (1994) Jennerian and modified Jennerian approach to vaccination against totavirus diahrrea in infants and young children: an introduction. In: Kapikian AZ (ed) Viral infections of the gastrointestinal tract, 2nd edn. Dekker, New York, pp 409–415

    Google Scholar 

  58. Kapikian AZ (2011) History of rotavirus vaccines. Part I: RotaShield. In: Plotkin S (ed) History of vaccine development. Springer, New York/Dordrecht/Heidelberg/London, pp 285–314

    Chapter  Google Scholar 

  59. Kapikian AZ, Hoshino Y, Chanock RM et al (1996) Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children. J Infect Dis 174:S65–S72

    Article  PubMed  Google Scholar 

  60. Kapikian AZ, Simonsen L, Vesikari T et al (2005) A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception. J Infect Dis 192:S22–S29

    Article  PubMed  Google Scholar 

  61. Keusch GT, Cash RA (1997) A vaccine against rotavirus – when is too much too much? N Engl J Med 337:1228–1229

    Google Scholar 

  62. Lanata CF, Black RE, del Aguila R et al (1989) Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine. J Infect Dis 159:452–459

    Article  CAS  PubMed  Google Scholar 

  63. Lanata CF, Midthun K, Black RE et al (1996) Safety, immunogenicity, and protective efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima, Peru. J Infect Dis 174:268–275

    Article  CAS  PubMed  Google Scholar 

  64. Lanzieri TM, Costa I, Shafi FA et al (2010) Trends in hospitalizations from all-cause gastroenteritis in children younger than 5 years of age in Brazil before and after human rotavirus vaccine introduction. Pediatr Infect Dis 29:673–675

    Article  Google Scholar 

  65. Lanzieri TM, Linhares AC, Costa I et al (2011) Impact of rotavirus vaccinations on childhood deaths from diarrhea in Brazil. Int J Infect Dis 15:206–210

    Article  Google Scholar 

  66. Linhares AC, Bresee JS (2000) Rotavirus vaccines and vaccination in Latin America. Rev Panam Salud Publica 8:305–331

    Article  CAS  PubMed  Google Scholar 

  67. Linhares AC, Gabbay YB, Mascarenhas JD et al (1996) Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil. Bull World Health Organ 74:491–500

    CAS  PubMed  PubMed Central  Google Scholar 

  68. Linhares AC, Justino MCA (2014) Rotavirus vaccination in Brazil: effectiveness and health impact seven years post-introduction. Expert Rev Vaccines 13:43–57

    Article  CAS  PubMed  Google Scholar 

  69. Linhares AC, Lanata CF, Hausdorff WP et al (1999) Reappraisal of the Peruvian and Brazilian lower titer tetravalent rhesus-human reassortant rotavirus vaccine efficacy trials: analysis by severity of diarrhea. Pediatr Infect Dis J18:1001–1006

    Article  Google Scholar 

  70. Linhares AC, Velázquez FR, Pérez-Schael I et al (2008) Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 371:1181–1189

    Article  CAS  PubMed  Google Scholar 

  71. Lopman BA, Pitzer VE, Sarkar R et al (2012) Understanding reduced rotavirus vaccine efficacy in low socio-economic settings. PLoS One 7:e41720

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Luna EJ, Frazatti-Gallina NM, Timenetsky MC et al (2013) A phase I clinical trial of a new 5-valent rotavirus vaccine. Vaccine 31:1100–1105

    Article  CAS  PubMed  Google Scholar 

  73. Madhi SA, Cunliffe NA, Steele D et al (2010) Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 362:289–298

    Article  CAS  PubMed  Google Scholar 

  74. Matthijnssens J, Nakagomi O, Kirkwood CD et al (2012) Group A rotavirus universal mass vaccination: how and to what extent will selective pressure influence prevalence of rotavirus genotypes? Expert Rev Vaccines 11:1347–1354

    Article  CAS  PubMed  Google Scholar 

  75. Matthijnssens J, Van Ranst M (2012) Genotype constellation and evolution of group A rotaviruses infecting humans. Curr Opin Virol 2:426–433

    Article  CAS  PubMed  Google Scholar 

  76. Midthun K, Greenberg HB, Hoshino Y et al (1985) Reassortant rotaviruses as potential live rotavirus vaccine candidates. J Virol 53:949–954

    CAS  PubMed  PubMed Central  Google Scholar 

  77. Midthun K, Kapikian AZ (1996) Rotavirus vaccines: an overview. Clin Microbiol Rev 9:423–434

    CAS  PubMed  PubMed Central  Google Scholar 

  78. Molto Y, Cortes JE, de Oliveira LH et al (2011) Reduction of diarrhea-associated hospitalizations among children aged <5 years in Panama following the introduction of rotavirus vaccine. Pediatr Infect Dis J 30:S16–S20

    Article  PubMed  Google Scholar 

  79. Munford V, Gilio AE, de Souza EC (2009) Rotavirus gastroenteritis in children in 4 regions in Brazil: a hospital-based surveillance study. J Infect Dis 200:S106–S113

    Article  PubMed  Google Scholar 

  80. Murphy BR, Morens DM, Simonsen L et al (2003) Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions. J Infect Dis 187:1301–1308

    Article  PubMed  Google Scholar 

  81. Murphy TV, Gargiullo PM, Massoudi MS et al (2001) Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 344:564–572

    Article  CAS  PubMed  Google Scholar 

  82. O’Ryan M, Lucero Y, Linhares AC (2011) Rotarix®: vaccine performance 6 years postlicensure. Expert Rev Vaccines 10:1645–1659

    Article  PubMed  CAS  Google Scholar 

  83. Orozco M, Vasquez J, Pedreira C et al (2009) Uptake of rotavirus vaccine and national trends of acute gastroenteritis among children in Nicaragua. J Infect Dis 200:S125–S130

    Article  PubMed  Google Scholar 

  84. Parashar UD, Cortese MM, Payne DC et al (2015) Value of post-licensure data on benefits and risks of vaccination to inform vaccine policy: the example of rotavirus vaccines. Vaccine 33:D55–D59

    Article  PubMed  Google Scholar 

  85. Patel MM, Lopes-Collada VR, Bulhões MM et al (2011) Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med 364:2283–2292

    Article  CAS  PubMed  Google Scholar 

  86. Patel M, Pedreira C, de Oliveira LG et al (2009) Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA 301:2243–2251

    Article  CAS  PubMed  Google Scholar 

  87. Patel M, Pedreira C, de Oliveira LH et al (2016) Effectiveness of pentavalent rotavirus vaccine against a diverse range of circulating strains in Nicaragua. Clin Infect Dis 62:S127–S132

    Article  PubMed  Google Scholar 

  88. Patel MM, Patzi M, Pastor D et al (2013) Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study. BMJ 346:f3726

    Article  PubMed  PubMed Central  Google Scholar 

  89. Patel MM, Steele D, Gentsch JR et al (2011) Real-world impact of rotavirus vaccination. Pediatr Infect Dis J 30:S1–S5

    Article  PubMed  Google Scholar 

  90. Peláez-Carvajal D, Cotes-Cantillo K, Caicedo-Paternina A et al (2014) Characterization of rotavirus genotypes before and after the introduction of a monovalent rotavirus vaccine in Colombia. J Med Virol 86:1083–1086

    Article  PubMed  Google Scholar 

  91. Pérez ME, Glass R, Alvarez G et al (2000) Rhesus rotavirus-based quadrivalent vaccine is efficacious despite age, socioeconomic conditions and seasonality in Venezuela. Vaccine 19:976–981

    Article  Google Scholar 

  92. Pérez Schael I (2012) Vacuna de Rotavirus. Una agenda global para su desarrollo y aplicación universal. Editorial Médica Panamericana, Colombia

    Google Scholar 

  93. Pérez-Schael I, Garcia D, Gonzalez M et al (1990) Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine. J Med Virol 30:219–229

    Article  PubMed  Google Scholar 

  94. Pérez-Schael I, Guntiñas MJ, Pérez M et al (1997) Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med 337:1181–1187

    Article  PubMed  Google Scholar 

  95. Pérez-Schael I, O’Ryan M, Saez-Llorens X et al (2012) The Latin American experience. Trials Vaccinol 1:10–20

    Article  Google Scholar 

  96. Pérez-Schael I, Salinas B, Tomat M et al (2007) Efficacy of the human rotavirus vaccine RIX4414 in malnourished children. J Infect Dis 196:537–540

    Google Scholar 

  97. Phua KB, Lim FS, Lau YL et al (2012) Rotavirus vaccine RIX4414 efficacy sustained during the third year of life: a randomized clinical trial in an Asian population. Vaccine 30:4552–4557

    Article  CAS  PubMed  Google Scholar 

  98. Pollard SL, Malpica-Llanos T, Friberg IK et al (2015) Estimating the herd immunity effect of rotavirus vaccine. Vaccine 33:3795–3800

    Article  PubMed  Google Scholar 

  99. Quintanar-Solares M, Yen C, Richardson V et al (2011) Impact of rotavirus vaccination on diarrhea-related hospitalizations among children <5 years of age in Mexico. Pediatr Infect Dis J 30:S11–S15

    Article  PubMed  Google Scholar 

  100. Rheingans RD, Constenla D, Antil L et al (2007) Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries. Rev Panam Salud Publica 21:205–216

    Article  PubMed  Google Scholar 

  101. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M et al (2010) Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med 362:299–305

    Article  CAS  PubMed  Google Scholar 

  102. Rosillon D, Buyse H, Friedland LR et al (2015) Risk of intussusception after rotavirus vaccination: meta-analysis of postlicensure studies. Pediatr Infect Dis J 34:763–768

    Article  PubMed  Google Scholar 

  103. ROTA Council (2016). Rotavirus: common, severe, devastating, preventable. Available from: http://tinyurl.com/rota4all . Accessed 21 May 2016

  104. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR et al (2006) Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354:11–22

    Article  CAS  PubMed  Google Scholar 

  105. Sáez-Llorens X, Velázquez FR, Lopez P et al (2013) A multi-country study of intussusception in children under 2 years of age in Latin America: analysis of prospective surveillance data. BMC Gastroenterol 13:95

    Article  PubMed  PubMed Central  Google Scholar 

  106. Safadi MA, Berezin EN, Munford V et al (2010) Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo, Brazil. Pediatr Infect Dis J 29:1019–1022

    PubMed  Google Scholar 

  107. Salinas B, Pérez Schael I, Linhares AC et al (2005) Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: a randomized, placebo-controlled trial in Latin American infants. Pediatr Infect Dis J 24:807–816

    Article  PubMed  Google Scholar 

  108. Santosham M, Letson GW, Wolff M et al (1991) A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population. J Infect Dis 163:483–487

    Article  CAS  PubMed  Google Scholar 

  109. Santosham M, Moulton LH, Reid R et al (1997) Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations. J Pediatr 131:632–638

    Article  CAS  PubMed  Google Scholar 

  110. Simonsen L, Viboud C, Elixhauser A et al (2005) More on RotaShield and intussusception: the role of age at the time of vaccination. J Infect Dis 192:S36–S43

    Article  PubMed  Google Scholar 

  111. Velázquez FR, Colindres RE, Grajales C et al (2012) Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico. Pediatr Infect Dis J 31:736–744

    Article  PubMed  Google Scholar 

  112. Velázquez FR, Matson DO, Calva JJ et al (1996) Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 335:1022–1028

    Article  PubMed  Google Scholar 

  113. Vesikari T (1993) Clinical trials of live oral rotavirus vaccines: the Finnish experience. Vaccine 11:255–261

    Article  CAS  PubMed  Google Scholar 

  114. Vesikari T (1997) Rotavirus vaccines against diarrhoeal disease. Lancet 350:1538–1541

    Article  CAS  PubMed  Google Scholar 

  115. Vesikari T, Isolauri E, Delem A et al (1983) Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children. Lancet 2:807–811

    Google Scholar 

  116. Vesikari T, Isolauri E, Delem A et al (1985) Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. J Pediatr 107:189–194

    Article  CAS  PubMed  Google Scholar 

  117. Vesikari T, Isolauri E, D’Hondt E et al (1984) Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet 1:977–981

    Article  CAS  PubMed  Google Scholar 

  118. Vesikari T, Itzler R, Matson DO et al (2007) Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries). Int J Infect Dis 11:S29–S35

    Article  PubMed  Google Scholar 

  119. Vesikari T, Karnoven A, Ferrante SA et al (2010) Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study. Eur J Pediatr 169:1379–1386

    Article  PubMed  PubMed Central  Google Scholar 

  120. Vesikari T, Karvonen A, Prymula R et al (2007) Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 370:1757–1763

    Article  CAS  PubMed  Google Scholar 

  121. Vesikari T, Karvonen A, Puustinen L et al (2004) Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants. Pediatr Infect Dis J 23:937–943

    Article  PubMed  Google Scholar 

  122. Vesikari T, Karvonen AV, Majuri J et al (2006) Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children. J Infect Dis 194:370–376

    Article  PubMed  Google Scholar 

  123. Vesikari T, Matson DO, Dennehy P et al (2006) Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354:23–33

    Article  CAS  PubMed  Google Scholar 

  124. Vesikari T, Ruuska T, Koivu HP et al (1991) Evaluation of the M37 human rotavirus vaccine in 2- to 6-month-old infants. Pediatr Infect Dis J 10:912–917

    Article  CAS  PubMed  Google Scholar 

  125. Vieira SCF, Gurgel RQ, Kirby A et al (2011) Acute diarrhoea in a community cohort of children who received an oral rotavirus vaccine in Northeast Brazil. Mem Inst Oswaldo Cruz 106:330–334

    Article  PubMed  Google Scholar 

  126. Weijer C (2000) The future of research into rotavirus vaccine. Benefits of vaccine may overweight risk for children in developing countries. BMJ 321:525–526

    CAS  Google Scholar 

  127. WHO (2009) Global advisory committee on vaccine safety report. Wkly Epidemiol Rec 84:213–236

    Google Scholar 

  128. WHO (2014) Update on intussusception following rotavirus vaccine administration: World Health Organization 2014. Available from: http:www.who.int/vaccine_safety/committee/topics/rotavirus/rotarix_and_rotateq/dec_2013/en/ . Accessed 21 May 2016

  129. Yen C, Armero Guardado JÁ, Alberto P et al (2011) Declines in rotavirus hospitalization and health care visits for childhooh diarrhea following rotavirus vaccination in El Salvador. Pediatr Infect Dis J 30:S6–S10

    Article  PubMed  Google Scholar 

  130. Yen C, Tate JE, Hyde TB et al (2014) Rotavirus vaccines: current status and future considerations. Hum Vaccin Immunother 10:1436–1448

    Article  PubMed  PubMed Central  Google Scholar 

  131. Zade JK, Kulkarni PS, Desai SA et al (2014) Bovine rotavirus pentavalent vaccine development in India. Vaccine 32S:A124–A128

    Article  Google Scholar 

  132. Zaman K, Dang DA, Victor JC et al (2010) Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 376:615–623

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Instituto de Biomedicina, Enteric Disease Section, Universidad Central de Venezuela, Ministerio de Sanidad, Caracas, Venezuela

    Irene Pérez-Schael MSc

  2. Instituto Evandro Chagas, Virology Section, Health Surveillance Secretariat, Brazilian Ministry of Health, Belém, Pará, Brazil

    Alexandre C. Linhares MD, PhD

Authors
  1. Irene Pérez-Schael MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alexandre C. Linhares MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Irene Pérez-Schael MSc or Alexandre C. Linhares MD, PhD .

Editor information

Editors and Affiliations

  1. Instituto Politécnico Nacional, Center for Research and Advances Studies, Mexico City, Mexico

    Juan Ernesto Ludert

  2. Centro de Microbiologia y Biologia Celular, Instituto Venezolano de Investigaciones Científicas (IVIC), Caracas, Venezuela

    Flor H. Pujol

  3. Facultad de Ciencias, Universidad de la Republica, Montevideo, Uruguay

    Juan Arbiza

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Pérez-Schael, I., Linhares, A.C. (2017). Rotavirus Vaccines: A Review of the Work, Progress, and Contributions Made in Latin America. In: Ludert, J., Pujol, F., Arbiza, J. (eds) Human Virology in Latin America. Springer, Cham. https://doi.org/10.1007/978-3-319-54567-7_21

Download citation

Publish with us

Policies and ethics

Search

Navigation